<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Based on clinical and pathological findings, <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) differs from other myeloproliferative/<z:mpath ids='MPATH_341'>myelodysplastic disorders</z:mpath> by its hallmark, <z:mp ids='MP_0000220'>monocytosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>It is unknown whether the presence of <z:mp ids='MP_0000220'>monocytosis</z:mp> and the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> carry a prognostic significance </plain></SENT>
<SENT sid="2" pm="."><plain>The present study aimed to determine whether the survival of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> differs from that of patients with BCR/ABL-negative <z:mp ids='MP_0005481'>CML</z:mp> or Ph(1-), BCR/ABL-unknown <z:mp ids='MP_0005481'>CML</z:mp>, once other potentially prognostic variables have been accounted for </plain></SENT>
<SENT sid="3" pm="."><plain>The records of 485 patients with myeloproliferative/<z:mpath ids='MPATH_341'>myelodysplastic disorders</z:mpath> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, n = 304; BCR/ABL-negative <z:mp ids='MP_0005481'>CML</z:mp>, n = 107; Ph(1-), BCR/ABL unknown, n = 74] were analysed </plain></SENT>
<SENT sid="4" pm="."><plain>Of the covariates found to be significantly (P &lt; 0.01) associated with survival in univariate and multivariate analyses, the following remained predictive and adversely associated with survival, after accounting for the influence of other covariates: increasing age, white blood cell count, platelets, bone marrow blasts and cellularity, decreasing <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, abnormal karyotype, and diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> is prognostically significant and independently associated with a shorter survival and a higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> than BCR/ABL-negative <z:mp ids='MP_0005481'>CML</z:mp> or Ph(1-) BCR/ABL-unknown <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
</text></document>